Patents by Inventor Jeffrey Richard LeBrun

Jeffrey Richard LeBrun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10869882
    Abstract: Immune function of an animal can be modulated by administration of a composition that includes beta glucan. The beta glucan can be derived from Euglena, which provides a form of beta glucan that is different from other organisms, where the beta glucan is predominantly unbranched beta-(1,3)-glucan. Beta glucan can also be complexed with a metal, such as zinc, and/or can combined with an animal feed component to form an animal feed composition. Use of such compositions can improve the well being of an animal, and may augment or even replace the use of antibiotics in certain circumstances.
    Type: Grant
    Filed: March 1, 2019
    Date of Patent: December 22, 2020
    Assignee: KEMIN INDUSTRIES, INC.
    Inventors: Jeffrey Richard LeBrun, Robert Levine, Geoffrey Paul Horst
  • Publication number: 20190262381
    Abstract: Immune function of an animal can be modulated by administration of a composition that includes beta glucan. The beta glucan can be derived from Euglena, which provides a form of beta glucan that is different from other organisms, where the beta glucan is predominantly unbranched beta-(1,3)-glucan. Beta glucan can also be complexed with a metal, such as zinc, and/or can combined with an animal feed component to form an animal feed composition. Use of such compositions can improve the well being of an animal, and may augment or even replace the use of antibiotics in certain circumstances.
    Type: Application
    Filed: March 1, 2019
    Publication date: August 29, 2019
    Inventors: Jeffrey Richard LeBrun, Robert Levine, Geoffrey Paul Horst
  • Patent number: 10265340
    Abstract: Immune function of an animal can be modulated by administration of a composition that includes beta glucan. The beta glucan can be derived from Euglena, which provides a form of beta glucan that is different from other organisms, where the beta glucan is predominantly unbranched beta-(1,3)-glucan. Beta glucan can also be complexed with a metal, such as zinc, and/or can combined with an animal feed component to form an animal feed composition. Use of such compositions can improve the well being of an animal, and may augment or even replace the use of antibiotics in certain circumstances.
    Type: Grant
    Filed: February 22, 2013
    Date of Patent: April 23, 2019
    Assignee: KEMIN INDUSTRIES, INC.
    Inventors: Jeffrey Richard LeBrun, Robert Levine, Geoffrey Paul Horst
  • Patent number: 9574217
    Abstract: Immune function of an animal can be modulated by administration of a composition that includes algae meal or beta glucan. The algae meal can be made by growing Euglena using particular methods and conditions, including certain continuous, semi-continuous, fed-batch, and repeat batch methods in sterile fermenters. Euglena provides a form of beta glucan that is different from other organisms, where the beta glucan is predominantly unbranched beta-1,3-glucan. Use of algae meal and beta glucan produced by the disclosed processes can improve the wellbeing of an animal or human, and may augment or even replace the use of antibiotics in certain circumstances.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: February 21, 2017
    Assignee: Algal Scientific Corporation
    Inventors: Robert Bernard Levine, Jeffrey Richard LeBrun, Geoffrey Paul Horst